Johnson & Johnson Is Maintained at Outperform by RBC Capital
Johnson & Johnson Analyst Ratings
Verb Surgical Granted US Patent # 12,108,928 B2 For MACHINE-LEARNING-BASED VISUAL-HAPTIC SYSTEM FOR ROBOTIC SURGICAL PLATFORMS
Johnson & Johnson's (NYSE:JNJ) Has Had A Decent Run On The Stock Market: Are Fundamentals In The Driver's Seat?
RBC Capital Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Raises Target Price to $178
Goldman Sachs Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Raises Target Price to $162